Concepedia
Statistics
Publications
7
Citations
241
H-Index
Active since
2016
Affiliations
UNSW Sydney(Current)
Roswell Park Comprehensive Cancer Center
Children's Cancer Institute Australia
The University of Western Australia
The Kids Research Institute Australia
Shiloh Middlemiss is an author at UNSW Sydney specializing in molecular oncology, oncology, and medicine.
Publications per year
2016–2020
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis
Lioubov G. Korotchkina, Denis Kazyulkin, Pavel G. Komarov et al. · Leukemia · 2020 · 64 citations · Full text
Medicine, Oncology, Pharmacology +12
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours
Kenneth Hsu, Shiloh Middlemiss, Federica Saletta et al. · Cancer Gene Therapy · 2020 · 46 citations · Full text
Medicine, Immunology, Oncology +14
Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia
Klaartje Somers, Angelika Kosciolek, Angelika Bongers et al. · International Journal of Cancer · 2019 · 43 citations · Full text
Medicine, Oncology, Pharmacology +10
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia
Klaartje Somers, Kathryn Evans, Leanna Cheung et al. · Leukemia · 2019 · 31 citations · Full text
Medicine, Cancer Biology, Oncology +15
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction
Klaartje Somers, Victoria W. Wen, Shiloh Middlemiss et al. · Oncogene · 2019 · 30 citations · Full text
Life Sciences, Medicinal Chemistry, Oncology +17
1–5 of 7